Further studies are needed to indicate whether metal and silica immunoreactive patients have a distinct disease phenotype or particular genetic variants comparable to the Glu at position 69 in HLA-DPB1 in CBD. This evidence concerns the gene HLA-DPB1 and red-green color blindness.